Skip to content

X80 RADiant Photoelectric Therapy System recallZ-1404-2022 · Xstrahl Limited · initiated Apr 27, 2022

Open, Classified

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Xstrahl Limited or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

There is a potential compatibility issue with the systems and replacement treatment applicators.

FDA root cause category: Finished device change control

What the company is doing

The firm sent out the recall notification on 04/27/2022 via email. The letter mentions the consignee is able to continue to use the system. The consignee is to ensure that the verification of selection of the correct applicator for the planned treatment is conducted with the consignee's procedures and radiotherapy professional practice and guidelines. They are asked to complete a response form and return it no later than 30 days.

Recall details

Recall number
Z-1404-2022
Status
Open, Classified
Initiated by the company
Apr 27, 2022
Recalling firm
Xstrahl Limited
Quantity
7 devices; 70 treatment applicators
Product code
JAD
FDA submissions
K172080
Distribution
US Distribution FL, CA, KY

Product description

X80 RADiant Photoelectric Therapy System

Code information (models, lots, serial numbers)

Model Number: X80 RADiant Photoelectric Therapy System; Lot Codes: GM0549, GM0567 GM0568, GM0569, GM0570, GM0571 and GM0577; UDI/DI: 5060494200008

Devices named in this recall

1 device in the FDA device registry whose identifier appears in the recall's code information.

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page